Apazone or azapropazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H20N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K2VOT966ZI, chemically known as 1,2-dihydro-3-dimethylamino-7-methyl-1,2-(propylmalonyl)-1,2,4-benzotriazine but generally known as apazone, which bears US NIH Compound Identifier 26098. Apazone most often comes in base and dihydrate forms. European Medicines Agency schedules Azapropazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05638MIG. The term AZAPROPAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules apazone in its Anatomical Therapeutic Chemical (ATC) Classification. Apazone or azapropazone bears US NLM identifiers UMLS ID C0003524 and NCI Concept Code C73074. SMILES: CCCC1C(=O)N2C3=C(C=CC(=C3)C)N=C(N2C1=O)N(C)C.